$98.05
0.590.61%
At close: Aug 31, 5:00 PM EST
$98.05
N/A
After Hours: 4:02 PM EST
Mirum Pharmaceuticals Inc
MIRMNASDAQ
Mirum Pharmaceuticals Earnings & Forecasts
Mirum Pharmaceuticals (MIRM) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Mirum Pharmaceuticals Guidance
Mirum Pharmaceuticals (MIRM) last issued guidance on August 5, 2026 for fiscal year 2026. The company guided revenue in the range of $680M - $700M for the period.
Compared to prior guidance, Mirum Pharmaceuticals raised its revenue forecast from a prior range of $660M - $680M.
Mirum Pharmaceuticals has issued 13 guidance updates between November 9, 2022 and August 5, 2026. During this period, the company raised its outlook 9 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.80 | $-0.36 | $0.04 | $-0.14 |
| Actual | $-0.80 | $-0.50 | $-0.12 | $0.05 |
| Surprise | 0.00% | -38.9% | -400.0% | +135.7% |
| Revenue | ||||
| Estimate | $165.5M | $148.2M | $141.6M | $131.1M |
| Actual | $176.2M | $159.9M | $148.9M | $133.0M |
| Surprise | +6.46% | +7.91% | +5.19% | +1.49% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.46 | $-0.61 | $-0.17 | $-0.14 |
| Revenue | ||||
| Consensus | $177.5M | $182.8M | — | — |
